Shatin, Hong Kong — 07/14/2025 — Xellera Therapeutics, a leader in molecular diagnostics and life sciences innovation, proudly announces the launch of its next-generation Polymerase Chain Reaction (PCR) platform—designed to deliver faster, more accurate, and highly sensitive genetic analysis for clinical and research applications.
Polymerase Chain Reaction (PCR) is a revolutionary technique that amplifies DNA sequences, enabling the detection of genetic material in even the smallest samples. From infectious disease testing to oncology and personalized medicine, PCR has become a cornerstone in modern diagnostics.
Our enhanced PCR platform represents a significant leap in molecular testing, delivering results with unprecedented speed and precision, Advances Molecular Diagnostics with Enhanced Polymerase Chain Reaction (PCR) Technology at Xellera Therapeutics. “We’re enabling labs, hospitals, and researchers to detect diseases earlier, monitor treatment progress, and improve patient outcomes.

Key Features of the New PCR Technology:

Ultra-High Sensitivity: Capable of detecting low-copy genetic targets.
Rapid Turnaround: Reduced amplification time with real-time results.
Multiplex Capabilities: Simultaneous detection of multiple genetic markers.
User-Friendly Interface: Designed for ease of use in both research and clinical labs.
Compliance with Global Standards: Fully validated for regulatory and diagnostic use.
The new PCR system is already being deployed in disease surveillance programs, oncology labs, and academic institutions globally. It supports a broad range of applications, including COVID-19 testing, genetic mutation analysis, pathogen detection, and forensic science.

About Xellera Therapeutics
Xellera Therapeutics is a global biotechnology innovator focused on advancing diagnostics, life science research, and personalized medicine. With a commitment to scientific excellence and patient care, the company continues to lead the way in transforming health outcomes through technology.

Media Contact:
Name: Xellera Therapeutics
Title: Advances Molecular Diagnostics with Enhanced Polymerase Chain Reaction (PCR) Technology
Email Address: [email protected]
Phone Number: +852 2618 3356
Website URL: http://www.xelleratherapeutics.com